59
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Short-term effect of simvastatin treatment on inflammatory parameters in peritoneal dialysis patients

, , , , &
Pages 436-441 | Received 27 Apr 2006, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anna Tomaszuk-Kazberuk, Marcin Kozuch, Jolanta Malyszko, Hanna Bachorzewska-Gajewska, Slawomir Dobrzycki & Wlodzimierz J. Musial. (2013) Pharmacologic Treatment in Dialysis Patients Hospitalized for Cardiovascular Reasons: Do We Follow the Guidelines?. Renal Failure 35:2, pages 235-242.
Read now

Articles from other publishers (11)

Dan-Ying Lee, Chi-Jung Huang, Wan-Yu Yeh, Shih-Hsien Sung, Chen-Huan Chen & Hao-Min Cheng. (2022) Improvement of clinical outcomes in patients undergoing peritoneal dialysis using hydroxymethylglutaryl-CoA reductase inhibitors: A systematic review and meta-analysis. Journal of the Chinese Medical Association 86:2, pages 155-165.
Crossref
Kamini, Anoop Kumar, Pooja A. Chawla & Bhupinder Kapoor. 2023. Recent Developments in Anti-Inflammatory Therapy. Recent Developments in Anti-Inflammatory Therapy 331 386 .
Jianting Wang, Ziwei Chen, Yuliang Qiu, Ling Wu, Huan Wang, Lisheng Wu, Liangbin Zhao & Dengpiao Xie. (2022) Statins Have an Anti-Inflammation in CKD Patients: A Meta-Analysis of Randomized Trials. BioMed Research International 2022, pages 1-12.
Crossref
Roberto Pontremoli, Vincenzo Bellizzi, Stefano Bianchi, Roberto Bigazzi, Valeria Cernaro, Lucia Del Vecchio, Luca De Nicola, Giovanna Leoncini, Francesca Mallamaci, Carmine Zoccali & Michele Buemi. (2020) Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology. Journal of Nephrology 33:3, pages 417-430.
Crossref
Reza Tabrizi, Omid Reza Tamtaji, Naghmeh Mirhosseini, Kamran B. Lankarani, Maryam Akbari, Ehsan Dadgostar, Afshin Borhani-Haghighi, Payam Peymani, Fariba Ahmadizar & Zatollah Asemi. (2019) The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research 141, pages 85-103.
Crossref
Yalcin Solak & Halil Zeki Tonbul. 2014. Dyslipidemias in Kidney Disease. Dyslipidemias in Kidney Disease 179 202 .
Alfonso M. Cueto-Manzano, Juan R. Ángel-Zúñiga, Gabina Ornelas-Carrillo, Enrique Rojas-Campos, Héctor R. Martínez-Ramírez & Laura Cortés-Sanabria. (2013) Anti-Inflammatory Interventions in End-stage Kidney Disease: A Randomized, Double-Blinded, Controlled and Crossover Clinical Trial on the Use of Pravastatin in Continuous Ambulatory Peritoneal Dialysis. Archives of Medical Research 44:8, pages 633-637.
Crossref
Suetonia C Palmer, Sankar D Navaneethan, Jonathan C Craig, David W Johnson, Vlado Perkovic, Sagar U Nigwekar, Jorgen Hegbrant & Giovanni FM Strippoli. (2013) HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database of Systematic Reviews.
Crossref
JIN DENG, QIAOYUAN WU, YUNHUA LIAO, DONGMEI HUO & ZHENHUA YANG. (2012) Effect of statins on chronic inflammation and nutrition status in renal dialysis patients: A systematic review and meta-analysis. Nephrology 17:6, pages 545-551.
Crossref
Vera Krane & Christoph Wanner. (2011) Statins, inflammation and kidney disease. Nature Reviews Nephrology 7:7, pages 385-397.
Crossref
Xiang-Yang Li, Ju-Ping Chang, Zhuo-Wa Su, Jiu-Hong Li, Bo-Shen Peng, Sheng-Lang Zhu, An-Ji Cai, Jun Zhang & Ying Jiang. (2009) How Does Short-Term Low-Dose Simvastatin Influence Serum Prohepcidin Levels in Patients With End-Stage Renal Disease? A Pilot Study. Therapeutic Apheresis and Dialysis 14:3, pages 308-314.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.